LUNAR: Pivotal, Randomized, Open-Label Study of Tumor Treating Fields (Ttfields) Concurrent with Standard of Care Therapies for Treatment of Stage 4 Non-Small Cell Lung Cancer (NSCLC) Following Platinum Failure

The following study has recently been activated for patient enrollment by The University of Illinois Cancer Center Clinical Trials Office (CTO). Click on the link to learn about the details regarding the study on clinicaltrials.gov. For more information or questions about a study, email [email protected] or call 312-355-5112.

LUNAR: Pivotal, Randomized, Open-Label Study of Tumor Treating Fields (Ttfields) Concurrent with Standard of Care Therapies for Treatment of Stage 4 Non-Small Cell Lung Cancer (NSCLC) Following Platinum Failure

Sponsor: Novocure Ltd.
Principal Investigator: Lawrence Feldman, MD